We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Greenwich LifeSciences
GLSI
$191M
| $2.13M | ﹤0.01% |
+88,717
| New | +$2.31M |
|
2227
IBEX
IBEX
$448M
| $2.13M | ﹤0.01% |
79,271
-24,633
| -24% | -$797K |
|
2228
iQIYI
IQ
$1.18B
| $2.12M | ﹤0.01% |
1,572,743
-73,200
| -4% | -$126K |
|
2229
Under Armour
UAA
$3B
| $2.12M | ﹤0.01% |
358,108
+116,431
| +48% | +$755K |
|
2230
Astrana Health
ASTH
$2B
| $2.11M | ﹤0.01% |
86,137
+538
| +0.6% | +$12.7K |
|
2231
Ivanhoe Electric
IE
$1.43B
| $2.11M | ﹤0.01% |
178,628
+646
| +0.4% | +$10.1K |
|
2232
Vertex
VERX
$1.92B
| $2.1M | ﹤0.01% |
177,002
+37,711
| +27% | +$587K |
|
2233
CRA International
CRAI
$1.1B
| $2.1M | ﹤0.01% |
12,945
+77
| +0.6% | +$13.9K |
|
2234
Under Armour Class C
UA
$2.92B
| $2.09M | ﹤0.01% |
360,623
+102,629
| +40% | +$648K |
|
|
EXK
2235
Endeavour Silver
EXK
$2.32B
| $2.08M | ﹤0.01% |
224,019
| – | – |
|
2236
BioLife Solutions
BLFS
$1.46B
| $2.08M | ﹤0.01% |
109,182
-2,774
| -2% | -$61.3K |
|
|
SEZL
2237
Sezzle
SEZL
$5.17B
| $2.08M | ﹤0.01% |
32,886
+719
| +2% | +$49K |
|
2238
Theravance Biopharma
TBPH
$874M
| $2.07M | ﹤0.01% |
127,678
+38,690
| +43% | +$684K |
|
2239
Cooper-Standard Automotive
CPS
$504M
| $2.07M | ﹤0.01% |
74,343
-364
| -0.5% | -$12.2K |
|
2240
Precigen
PGEN
$1.93B
| $2.07M | ﹤0.01% |
534,011
+5,052
| +1% | +$20.7K |
|
2241
Brown-Forman Class A
BF.A
$12.3B
| $2.06M | ﹤0.01% |
76,947
+19,327
| +34% | +$526K |
|
2242
Primis Financial Corp
FRST
$382M
| $2.06M | ﹤0.01% |
155,225
+10,380
| +7% | +$139K |
|
2243
Merchants Bancorp
MBIN
$2.19B
| $2.05M | ﹤0.01% |
47,878
+1,160
| +2% | +$47.3K |
|
2244
Telos
TLS
$337M
| $2.05M | ﹤0.01% |
489,342
+278,200
| +132% | +$1.32M |
|
2245
Middlesex Water
MSEX
$1.05B
| $2.04M | ﹤0.01% |
39,160
+226
| +0.6% | +$11.9K |
|
2246
Ameresco
AMRC
$1.15B
| $2.03M | ﹤0.01% |
79,732
+612
| +0.8% | +$18.3K |
|
2247
Pacira BioSciences
PCRX
$1.02B
| $2.03M | ﹤0.01% |
89,806
-162,178
| -64% | -$3.6M |
|
|
BLSH
2248
Bullish
BLSH
$3.63B
| $2.02M | ﹤0.01% |
56,622
-25,796
| -31% | -$905K |
|
2249
John B. Sanfilippo & Son
JBSS
$949M
| $2.02M | ﹤0.01% |
25,443
-348
| -1% | -$26.8K |
|
2250
Fluence Energy
FLNC
$1.78B
| $2.02M | ﹤0.01% |
146,469
-24,608
| -14% | -$494K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.